Choi, Jee-Eun
Sebastian, Carlos
Ferrer, Christina M.
Lewis, Caroline A. http://orcid.org/0000-0003-1787-5084
Sade-Feldman, Moshe
LaSalle, Thomas http://orcid.org/0000-0002-8390-6072
Gonye, Anna http://orcid.org/0000-0003-0034-1756
Lopez, Begona G. C.
Abdelmoula, Walid M. http://orcid.org/0000-0003-3117-7389
Regan, Michael S.
Cetinbas, Murat
Pascual, Gloria http://orcid.org/0000-0003-3810-6647
Wojtkiewicz, Gregory R. http://orcid.org/0000-0002-3148-8411
Silveira, Giorgia G. http://orcid.org/0000-0003-1798-0191
Boon, Ruben http://orcid.org/0000-0002-9355-674X
Ross, Kenneth N.
Tirosh, Itay http://orcid.org/0000-0001-5477-2987
Saladi, Srinivas V.
Ellisen, Leif W. http://orcid.org/0000-0003-0444-7910
Sadreyev, Ruslan I.
Benitah, Salvador Aznar http://orcid.org/0000-0002-9059-5049
Agar, Nathalie Y. R.
Hacohen, Nir http://orcid.org/0000-0002-2349-2656
Mostoslavsky, Raul http://orcid.org/0000-0002-7740-5212
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01GM128448, R01CA175727)
Article History
Received: 24 September 2020
Accepted: 20 January 2021
First Online: 22 February 2021
Competing interests
: R.M. has a financial interest in Galilei Biosciences, a company developing activators of the mammalian SIRT6 protein. R.M.’s interests were reviewed and are managed by MGH and MGB HealthCare in accordance with their conflict-of-interest policies. N.H. has equity in BioNTech and Related Sciences. N.Y.R.A. is a key opinion leader to Bruker Daltonics. The other authors declare no competing interests.